Menarini inaugurates new regional headquarters in Dubai, UAE
PR96213
DUBAI, UAE, May 26, 2022 /PRNewswire=KYODO JBN/ --
The pharmaceutical group, present in 140 countries in the world, aims to raise
standard of patient healthcare across the Middle East and Africa (MEA) region
with innovative products and breakthrough research
Menarini, the leading Italian pharmaceutical group founded in 1886, today
opened its regional headquarters in Dubai Science Park as part of its goal to
expand its presence to the Middle East and Africa (MEA) region. Specializing in
pharmaceutical research and production, consumer healthcare, oncology, and
diagnostics, the Group is basing its new regional office, Menarini Middle East
and Africa, in Dubai as it acts as an ideal hub location to elevate patient
health and wellbeing in the region and to form pivotal connections with key
industry stakeholders.
The inauguration drew the participation of influential healthcare dignitaries,
most notably H.E. Dr. Amin Hussain Al Amiri, Assistant Undersecretary of Public
Health Policy and Licensing at the UAE Ministry of Health and Prevention; H.E.
Nicola Lener, Ambassador of Italy to the UAE, as well as high-level executives
from Menarini's global team, as Dr Luca Lastrucci ,Group General Manager, Dr
Ugur Bingol META President and Dr Basel Thaher Middle East Regional Head and
MEA General Manager.
Elcin Barker Ergun, CEO Menarini Group and Member of the Board of Directors,
said: "Today marks a historical moment for us as we open our regional offices
in Dubai, a key inflection point, to significantly grow our presence and
portfolio in the Middle East. As a 135 years old family owned company, we are
looking forward to serve many more patients in the Middle East in the coming
years with our unwavering commitment to Quality."
Luca Lastrucci, Group General Manager at Menarini, commented: "Today's
inauguration of our MEA headquarters in Dubai is a significant milestone for
our company as we expand our investments in the MEA region. Our presence in a
leading pharmaceutical hub like Dubai will strengthen Menarini's capabilities
and improve market access in delivering breakthrough products in the areas of
cardiovascular, gastrointestinal, and inflammatory diseases." Lastrucci added:
"The UAE government has shown unwavering support for pharmaco-economic
investments through its solid commercial infrastructure and impressive
facilities. We see this as a vital step in the right direction for Menarini and
will continue to work side-by-side with the UAE government to raise healthcare
standards and support the wellbeing of communities across the UAE and
beyond."
Commenting on Menarini's new regional launch being perfectly aligned with the
Dubai Industrial Strategy 2030, Dr. Ali Al Sayed, Director of Pharmaceutical
Services Department at the Dubai Health Authority, said: "A defining objective
of Dubai's 2030 strategy is to be a global hub for knowledge-based, sustainable
and innovation focused businesses. As Menarini is a company with longstanding
roots based in medical research, it will be a strong contributor to this
visionary strategy. Together, we share Dubai's overarching healthcare vision
of positioning Dubai as the leading destination for healthcare knowledge,
education and training."
Present in 140 countries with over 17,000 employees, the new Menarini regional
headquarters in Dubai will be guided by Menarini's deeply rooted values of
being patient-focused, people centered, and being committed to quality,
integrity, and responsibility. This important milestone serves as a testament
to Menarini's ongoing mission of curing diseases on a global scale and
prioritizing patient health above all else.
About Menarini
The Menarini Group is a leading international pharmaceutical and diagnostics
company, with a turnover of more than $4 billion and over 17,000 employees.
Menarini is focused on therapeutic areas with high unmet needs with products
for cardiology, oncology, pneumology, gastroenterology, infectious diseases,
diabetology, inflammation and analgesia. With 18 production sites and 9
Research and Development centers, Menarini's products are available in 140
countries worldwide. For further information, please visit www.menarini.com.
Photo - https://mma.prnewswire.com/media/1826819/Menarini_1.jpg
Photo - https://mma.prnewswire.com/media/1826820/Menarini_2.jpg
Logo - https://mma.prnewswire.com/media/652491/MENARINI_Group_Logo.jpg
Source: Menarini Industrie Farmaceutiche Riunite
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。